PFM Health Sciences, LP
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1442756
SAN FRANCISCO, CA
Position in AMLX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,580,852
+$561,530 QoQ
Shares Held
143,700
-1.1% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#72
of 205 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PFM Health Sciences, LP holds $121,812,965 across 10 Drug Manufacturers - Specialty & Generic names. AMLX ranks #8 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
213,407 | $35,967,615 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
49,991 | $27,086,623 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
401,208 | $16,461,564 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
146,403 | $16,241,948 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
|
480,715 | $8,321,176 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
444,173 | $7,120,093 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
172,489 | $4,244,954 | |
| 8 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
143,700 | $2,580,852 |
All Filings in AMLX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,580,852 | 143,700 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,019,322 | 145,275 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,625,351 | 134,549 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,927,360 | 436,156 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,693,760 | 732,256 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,952,837 | 834,135 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||